Lichen China's EBIT is $-19M, below the sector sector average of $-6.4M.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2025
Trailing 12 months ending Dec 31, 2025
Lichen China (LICN) currently reports a EBIT of $-19M as of December 2025. That compares with $12M in the prior-year period — down 254.6% year over year. That is below the sector sector average of $-6.4M. Use the charts on this page to explore Lichen China's EBIT history and peer comparisons.
Lichen China's EBIT decreased from $12M to $-19M — a 254.6% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Lichen China's EBIT of $-19M is lower than the its sector sector average of $-6.4M. That is roughly 196.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Lichen China reported $-19M in EBIT as of December 2025. That compares with $12M in the prior-year period — down 254.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $-19M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-6.4M. From there, open related valuation or income-statement pages for Lichen China, and consider following LICN for alerts when major investors trade the stock.